Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
about
Proposal for the Rapid Reversal of Coagulopathy in Patients with Nonoperative Head Injuries on Anticoagulants and/or Antiplatelet Agents: A Case Study and Literature Review.How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors. Working group of hematology experts from Australia and New Zealand, Melbourne, April 2011.Are stroke units cost effective? Evidence from a New Zealand stroke incidence and population-based study.
P2860
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@ast
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@en
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@nl
type
label
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@ast
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@en
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@nl
prefLabel
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@ast
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@en
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@nl
P2860
P356
P1433
P1476
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
@en
P2860
P2888
P356
10.1186/1471-2377-8-17
P577
2008-05-19T00:00:00Z
P5875
P6179
1006274931